Sulfated hyaluronic acid gel for the treatment of rheumatoid arthritis in rats

• Published in: International journal of biological macromolecules Vol. 256; no. Pt 2; p. 128537
• Main Authors: Yue, Yingxue, Shi, FanLi, Wang, Jing, Ning, Qing, Zhang, Zhenhai, Lv, Huixia
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01-01-2024
• Subjects: Hyaluronic acid; Rheumatoid arthritis; Sulfation; Hyaluronic acid; Rheumatoid arthritis; Sulfation
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2023.128537

Rheumatoid arthritis (RA) is a chronic autoimmune disease. NSAIDS, cyclophosphamide and glucocorticoid were commonly used to treat RA in clinical application, which long-term administration of these drugs caused serious adverse reactions. Therefore, sulfated hyaluronic acid (sHA) gel (SG) was prepared to firstly treat the RA and avoid the problem of toxic side effect caused by long-term application. In vitro evaluation showed that sHA inhibited the level of reactive oxygen species and TNF-α, IL-1β, and IL-6, and decreased the ratio of macrophage M1/M2 type, which exerted better anti-inflammatory capacity. In vivo studies showed that the injection of SG into the joint cavity of collagen-induced rheumatoid arthritis (CIA) rats could effectively treat joint swelling and reduce the level of inflammatory factors in the serum. Immunofluorescence showed that SG exerted its anti-inflammatory activity by decreasing the ratio of M1/M2 type macrophages in synovial tissue. Cartilage tissue sections showed that SG reduced bone erosion and elevated chondrocyte expression. These results confirmed that sHA is expected to be developed as a drug to treat or relieve RA, which could effectively regulate the level of macrophages in rat RA, alleviate the physiological state of inflammatory over-excitation, and improve its anti-inflammatory and antioxidant capacity.
[Display omitted]
•mHA was modified by sulfation to synthesize sHA.•SG reduced ratio of MI/M2 type macrophages in inflammatory cells and rats.•SG decreased synovial tissue proliferation and increased Col II and chondrocytes.